US2008032981A1PendingUtilityA1

Aryl n-cyanoguanidines and methods related thereto

Assignee: MIGENIX CORPPriority: Feb 27, 2001Filed: May 4, 2007Published: Feb 7, 2008
Est. expiryFeb 27, 2021(expired)· nominal 20-yr term from priority
A61P 37/00A61P 43/00A61P 3/10A61P 35/00A61P 29/00A61P 27/02A61P 25/16A61P 27/16A61P 25/18A61P 25/28A61P 21/00A61K 31/155C07C 279/28A61K 31/5375A61P 19/02A61P 17/06
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compounds, compositions and methods treating arthritic disorders such as osteoarthritis or rheumatoid arthritis, and for treating other diseases associated with altered mitochondrial function, such as cancer, psoriasis, stroke, Alzheimer's Disease and diabetes. The compounds of this invention have the following structure (I): including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein R 1-5 are as defined herein. The methods of this invention are directed to administering to a warm-blooded animal in need thereof an effective amount of a compound of structure (I), typically in the form of a pharmaceutical composition.

Claims

exact text as granted — not AI-modified
1 - 16 . (canceled)  
   
   
       17 . A compound having the structure:  
     
       
         
         
             
             
         
       
     
   
   
       18 . A compound having the structure:

Join the waitlist — get patent alerts

Track US2008032981A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.